The desktop application qPSMA37a for the interactive quantification of whole-body tumor volume of patients with prostate cancer using prostate-specific membrane antigen–positron emission tomography/CT images, developed by the Department of Nuclear Medicine at the Technical University Munich, was integrated into such a semiautomatic workflow. The gene discussed is FOLH1; the disease is prostate carcinoma.